Biologics
Payments companies reported to CMS as associated with Biologics. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Biologics, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Biologics
These are the largest totals companies reported as associated with Biologics. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Timothy Kuklo | Denver, CO | Orthopaedic Surgery of The Spine | $87,339.26 |
| Juan Uribe | Phoenix, AZ | Neurological Surgery | $50,947.47 |
| Han Kim | New York, NY | Orthopaedic Surgery of The Spine | $29,700.00 |
| Frank Schwab | New York, NY | Orthopaedic Surgery of The Spine | $19,146.98 |
| William Kunkle | West Palm Beach, FL | Orthopaedic Surgery of The Spine | $13,706.22 |
| Anand Veeravagu | Palo Alto, CA | Neurological Surgery | $6,900.00 |
| Alp Ozpinar | Springfield, OR | Neurological Surgery | $5,765.24 |
| Samuel Goldsmit | Miami, FL | Neurological Surgery | $5,023.81 |
| Nima Alan | San Francisco, CA | Neurological Surgery | $4,230.95 |
| Gilbert Chan | Atlanta, GA | Pediatric Orthopaedic Surgery | $3,375.00 |
Prescribed Biologics?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.